Fig. 2From: Clinical impact of 99mTc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patientsKaplan–Meier curves for overall survival (OS) (A) and progression-free survival (PFS) (B). No statistically significant difference was seen between group A and B in OS or PFSBack to article page